Advertorial

Tecan and TAP Biosystems to automate RAFT™ 3D cell culturing on the Freedom EVO®

0
SHARES

Posted: 30 October 2012 | | No comments yet

Tecan and TAP Biosystems, a leading supplier of innovative cell culture systems, have announced a co-marketing agreement to further expand the automated 3D cell culture capabilities of the Freedom EVO® liquid handling platform. Automation of TAP’s collagen-based RAFT™ cell culture system will allow scientists to quickly and conveniently create 3D cell cultures in a 96-well, SBS-format.

TAP Biosystems equipment

The RAFT system will further extend the 3D cell culturing capabilities of the Freedom EVO platform

The RAFT 3D cell culture system uses biologically relevant concentrations of collagen matrix to ensure cells grow and proliferate in an environment closely resembling the native tissue. The Freedom EVO workstation is configured with a number of modules, including reagent and microplate cooling units and a heated shaking device, to provide fully automated preparation and maintenance of RAFT cell cultures. This ensures rapid, reliable creation of consistent and reproducible 3D cell cultures, offering walkaway processing for a wide range of cell biology applications.

 

SECURE YOUR FREE SPOT

 


This webinar explores how the pharmaceutical industry can move towards sustainable autonomous operations.

Realising autonomous pharmaceutical operations | 9 February 2026 | 10am

What you’ll discover:

  • Understand the key drivers of the pharmaceutical industry and how autonomous operations are shaping its future and driving IT-OT conversion
  • Explore the value of automation in enhancing operational efficiency and driving business growth for life sciences
  • Gain expert insight on the potential benefits of implementing automation solutions.

Register now – it’s free

Kevin Moore, Head of Applications and Solutions at Tecan, commented: “We are pleased to further expand our automated 3D cell culture portfolio to include the RAFT system. Working together with TAP Biosystems, we will be able to offer a complete solution for automated 3D cell culture.”

Dr Grant Cameron, TAP Biosystems’ RAFT Development Director, added: “RAFT is rapidly becoming a core secondary screening technology within drug discovery. This exciting collaboration will enable researchers to expand the power of the realistic collagen environment of RAFT, with substantially increased throughput to meet their cell-based screening requirements.”

To find out more about Tecan’s 3D cell culture solutions, visit www.tecan.com/3dcellculture

To find out more about the RAFT cell culture system, visit www.raft3dcellculture.com

Related organisations

Related people

Leave a Reply

Your email address will not be published. Required fields are marked *

Share via
Share via